In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to EAPC Ivory (& above) Members, Fellows of the ESC and Young combined Members

Prevalence of the cardiovascular risk factors in bulgarian female population

Session Poster Session III - Friday 08:30 - 12:30

Speaker Associate Professor Emil Manov

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2015

  • Topic : preventive cardiology
  • Sub-topic : Lipids
  • Session type : Poster Session

Authors : N Runev (Sofia,BG), E Manov (Sofia,BG), S Naydenov (Sofia,BG), T Donova (Sofia,BG)

Authors:
N Runev1 , E Manov1 , S Naydenov1 , T Donova1 , 1UMHAT Alexandrovska - Sofia - Bulgaria ,

Citation:

Objective: To evaluate the risk profile and the level of control of some modifiable cardiovascular risk factors (RF) in Bulgarian female population.

Methods: Pooled data from 3 cross-sectional studies, organized by the Working group of the Bulgarian Society of Cardiology on cardiovascular risk in women. These studies were performed between year 2011 and 2014, including consecutively a total number of 214 women, mean age 58.5±11.7 (22-87) years. The clinical investigations included: blood pressure (BP) measurement, waist circumference (WaC), height, weight and body mass index (BMI) calculation. All women completed a questionnaire, specifying the presence of cardiovascular risk factors and diseases as well as some demographic characteristics. Using a self-assessment test introduced by the National U.S Diabetes Association we assessed the risk for development of type 2 diabetes mellitus (DM) among the non-diabetic women.

Results: Arterial hypertension is the most prevalent cardiovascular risk factor present in 72.4% (n=152), followed by overweight/obesity – 63.9% (n=106), dyslipidemia – 31.0% (n=65), type 2 DM – 14,5,7% (n=31), smoking – 10.3% (n=22) and hormone-replacement therapy with oestrogenes – 4.2% (n=9).  The mean value of the systolic and diastolic BP is 139.5±18.8 (90-194) and 86.9±12.1 (60-120) mmHg respectively. The mean value of BMI is 28.4±6.4 (18-51) kg/m2 and WaC – 95.4±15.8 (56-132) ??. The calculated risk for development of type 2 DM in the non-diabetic female population is 9.88±4.4 (0-20).

Conclusion: Arterial hypertension is the most prevalent RF for cardiovascular complications among the analyzed Bulgarian female population, followed by overweight/obesity and dyslipidemia. The risk for development of type 2 DM in the non-diabetic women is moderate to high. The control of the most common modifiable cardiovascular RF remains unsatisfactory despite the available non-pharmacological and pharmacological options.

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are